Uveitis following the use of tumor necrosis factor α inhibitors: Comment on the article by Lim et al

Arthritis and Rheumatism

Volumn 58, Issue 5, 2008, Pages 1555-1556

  Scrivo, Rossana ^a   Spadaro, Antonio ^a   Spinelli, Francesca Romana ^a   Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANKYLOSING SPONDYLITIS; DISEASE REGISTRY; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LETTER; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RELAPSE; RHEUMATOID ARTHRITIS; UVEITIS;

ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOGLOBULIN G; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS;

EID: 43949120761     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23440     Document Type: Letter

References (6)

1. Lim LL, Fraunfelder FW, Rosenbaum JT. Do tumor necrosis factor Inhibitors cause uveitis? A registry-based study. Arthritis Rheum 2007;56:3248-52.
2. Braun J, Baraliakos X, Listing J, Sieper J. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept [review]. Arthritis Rheum 2005;52:2447-51.
3. Guignard S, Gossec L, Salliot C, Ruyssen-Witrand A, Luc M, Duclos M, et al. Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study. Ann Rheum Dis 2006;65:1631-4.
4. Sugita S, Takase H, Taguchi C, Mochizuki M. The role of soluble TNF receptors for TNF-α in uveitis. Invest Ophthalmol Vis Sci 2007;48:3246-52.
5. Reddy AR, Backhouse OC. Does etanercept induce uveitis? [letter]. Br J Ophthalmol 2003;87:925.
6. Taban M, Dupps WJ, Mandell B, Perez VL. Etanercept (enbrel)-associated inflammatory eye disease: case report and review of the literature. Ocul Immunol Inflamm 2006;14:145-50.